Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Share-based Compensation (2019 - 2025)

Historic Share-based Compensation for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $5.2 million.

  • Pulmonx's Share-based Compensation fell 1152.59% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.5 million, marking a year-over-year decrease of 223.62%. This contributed to the annual value of $23.0 million for FY2024, which is 386.41% up from last year.
  • Pulmonx's Share-based Compensation amounted to $5.2 million in Q3 2025, which was down 1152.59% from $6.2 million recorded in Q2 2025.
  • Pulmonx's 5-year Share-based Compensation high stood at $6.2 million for Q2 2025, and its period low was $2.3 million during Q1 2021.
  • Over the past 5 years, Pulmonx's median Share-based Compensation value was $5.2 million (recorded in 2025), while the average stood at $4.7 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first soared by 135408.81% in 2021, then crashed by 1152.59% in 2025.
  • Over the past 5 years, Pulmonx's Share-based Compensation (Quarter) stood at $3.0 million in 2021, then skyrocketed by 41.0% to $4.2 million in 2022, then skyrocketed by 31.81% to $5.6 million in 2023, then decreased by 1.34% to $5.5 million in 2024, then dropped by 6.46% to $5.2 million in 2025.
  • Its Share-based Compensation stands at $5.2 million for Q3 2025, versus $6.2 million for Q2 2025 and $5.6 million for Q1 2025.